Overview
This Webcast provides overview on usage of the New Antiviral Remdesivir introduced for treatment of COVID – 19 and Challenges in the management of COVID – 19 patients.
Faculty
Dr. Matteo Bassetti
MD PHD
Prof. of Infectious Diseases, Dept. of Health Science, Univ. of Genoa Head, Infectious Diseases Clinic, Hosp. Policlinico San Martino IRCCS, Italy.
Dr. Jaideep Gogtay
MBBS, MDExecutive Vice President and Global Chief Medical Officer, Cipla, Mumbai, India
Dr. Vasant Nagvekar
Director- Department of Infectious Diseases, Sir HN Reliance Foundation Hospital and consultant – Lilavati Hospital.Department of Infectious diseases, Fellowship ID, Lilavati Hospital, Mumbai, India
Dr Yatin Mehta
MD, MNAMS, FRCA, FAMS Chairman, Medanta Institute of Critical Care & Anaesthesiology, Gurgaon
Dr. Harjit Dumra
MBBS, MD (Internal Medicine)Consultant Interventional Pulmonologist Sleep Medicine and Critical Care Specialist Sterling Hospital Head, Dept of Critical Care, Sterling Hospital Director, Sparsh Chest Disease Center, Gujarat, India
Dr Rashmi Hegde
Vice-President, Medical Affairs, Cipla Ltd. Mumbai, IndiaVice-President, Medical Affairs, Cipla Ltd. Mumbai, IndiaResources
External Resources
REMDESIVIR: Evidence to Experience
Also Read
